GC
SZYM

Guggenheim Capital’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Guggenheim Capital’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,616
Closed -$76K – 3067
2015
Q4 		$76K Buy
30,616
+10,812
+55% +$32.1K ﹤0.01% 2862
2015
Q3 		$51K Sell
19,804
-5,455
-22% -$14.2K ﹤0.01% 2854
2015
Q2 		$79K Sell
25,259
-1,751
-6% -$6K ﹤0.01% 2922
2015
Q1 		$77K Buy
27,010
+1,433
+6% +$3.66K ﹤0.01% 2886
2014
Q4 		$66K Buy
+25,577
New +$112K ﹤0.01% 2891

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Guggenheim Capital's SZYM Position: Q1 2016 in Review

Guggenheim Capital sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2016, closing a stake of 30,616 shares — an estimated $76K sold.

Guggenheim Capital first reported a position in SZYM in Q4 2014 and held it in 5 quarters. The position peaked at $79K in Q2 2015. 99 funds tracked by Wall St. Rank hold SZYM as of Q1 2016.

  • Guggenheim Capital reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Guggenheim Capital sold 30,616 SOLAZYME INC COM STK (DE) shares in Q1 2016, an estimated $76K.
  • Guggenheim Capital first reported a position in SOLAZYME INC COM STK (DE) in Q4 2014 and held it in 5 quarters.
  • Guggenheim Capital's SOLAZYME INC COM STK (DE) position peaked at $79K in Q2 2015.
  • 99 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2016.

Based on Guggenheim Capital's 13F filing for Q1 2016, filed 16 May 2016.